SoPABS/SQSC117/19-20

Page 1 of 2

UNIVERSITY OF BRIGHTON

COVID-19 Course Delivery Statement 2020/21

School PABS

Name of Course(s) MSc Clinical Pharmacy

Are there minimum equipment requirements for students?

Yes – Internet access and PC/Laptop.

Minimum hardware requirements  Intel i5 or equivalent 

Windows 10 

8Gb RAM, 256Gb SSD 

Full HD screen 

Course Specific Delivery Statement:

The School of Pharmacy and Biomolecular Sciences are planning to deliver your course without the

need to modify course learning outcomes or structure. Some teaching and assessment will need to

be provided remotely, as social distancing requirements will prevent face-to-face large group

activities.

The School of Pharmacy and Biomolecular Sciences are prioritising key practical skills for face-to-

face delivery whilst social distancing requirements are in place. This will necessitate multiple

repeats of some elements in order to facilitate smaller group working – which may reduce the

number of hours each student spends in the laboratory in order to ensure delivery is possible for

everyone. Where this is the case, additional virtual learning, simulated practicals and data analyses

will be deployed. To ensure a full experience, that enables students to meet all the learning

outcomes and PSRB requirements, course teams are prioritising and redeveloping laboratory and

other practical exercises and assessments so students can experience and be assessed on each of

the essential skills relevant to their year of study. These will be augmented to original planned

hours where social distancing and timetabling constraints allow.

The MSc research project is a mandatory component of the course and is worth 60 credits. This module requires a strong research and skill development and therefore requires attendance. This module requires a strong research and skill development and therefore requires attendance. Some of this may be in the field such as in a hospital setting or within the PABS research laboratories.

If the circumstances restrict physical attendance in the university, alternative arrangements may be explored in consultation with the course-leader and module-leader. If there are no suitable variations then there may be a possibility to undertake another form of research project such as meta-analysis with remotely supervised project, molecular modelling, surveys, data mining of unpublished data analysis etc. This would be in line with the university’s procedure and evidence

SoPABS/SQSC117/19-20

Page 2 of 2

would need to be submitted to demonstrate why attendance is not possible on medical or visa grounds.

Lectures and tutorials will largely be delivered remotely, with a mixture of synchronous and

asynchronous activities, supplemented by directed learning and self-assessment activities, in line

with what would normally be expected of students at each stage of study. All modules will include

face-to-face activities with academic staff, either onsite or remotely. Some workshops, including

computer workshops, will be prioritised for onsite delivery where this is considered to be the most

effective means of ensuring learning.

COVID-19 Course Changes for 20/21

Details of Change

Assessment Methods Where your assessment would have been in person it will be replaced with online equivalents, until in person assessment becomes possible again. For example, this means that invigilated exams will be replaced by online tests or electronic take home papers, and face-to-face presentations will be conducted online or recorded. Some laboratory assessment tasks will be replaced by analysis of simulated data, and tasks that require hand drawn components will be submitted as scanned images instead of in paper format.

Page 1 of 13

PROGRAMME SPECIFICATION Final

PART 1: COURSE SUMMARY INFORMATION Course summary Final award MSc Clinical Pharmacy

Intermediate award PGCert Clinical Pharmacy (60 credits) PGDip Clinical Pharmacy (120 credits)

Course status Final Awarding body University of Brighton School Pharmacy and Biomolecular Sciences Location of study/ campus Normally Moulsecoomb Partner institution(s) Name of institution Host department Course status 1. 2. 3. Admissions Admissions agency Direct to School Entry requirements Include any progression opportunities into the course.

Check the University’s website for current entry requirements.

MPharm (2ii or above) or equivalent. International applicants require IELTS score of 6.5 overall, and not less than 6 in each parameter, OR equivalent. Applicants not meeting this requirement may undertake the Extended Masters with the following entry requirements:

• those with IELTS 6.0 with no component under 5.5 to take an 8 week course (20 hours per week), or

• those with IELTS 5.5 with no component under 5.5 to take a 12

week course (20 hours per week).

Valid Data and Barring Service (DBS) certificate.

Start date (mmm-yy) Normally September

September 2020

Mode of study Mode of study Duration of study (standard) Maximum registration period Full-time 1 year 3 years Part-time 2 or 3 years 4 or 5 years Sandwich Distance Course codes/categories UCAS code n/a Contacts Course Leader (or Course Development Leader)

Sian Williams

Admissions Tutor Sian Williams Examination and Assessment

External Examiner(s) Name Place of work Date tenure expires Kay Wood Aston University 31st December 2021

Page 2 of 13

Examination Board(s) (AEB/CEB)

PG Professional Joint AEB/CEB (modules shared with other courses may come under other external examiners and AEBs)

Approval and review

Approval date Review date

Validation May 20191 May 20242 Programme Specification April 20203 April 20214

Professional, Statutory and Regulatory Body 1 (if applicable):

56

Professional, Statutory and Regulatory Body 2 (if applicable):

Professional, Statutory and Regulatory Body 3 (if applicable):

PART 2: COURSE DETAILS AIMS AND LEARNING OUTCOMES Aims The aims of the course are to: 1. enable students to critically evaluate current research and practice. 2. develop the ability to identify and solve problems in clinical pharmacy. 3. develop organisational and investigative skills appropriate to independent problem solving. 4. produce graduates with critical thinking, integrative capabilities and problem-solving skills

appropriate at postgraduate level. 5. enable students to develop individual research abilities through independent work and complete a

piece of research. 6. facilitate students in the development of personal, social, behavioural and communication skills for

effective interaction with patients, colleagues and health care professionals. 7. produce graduates who can demonstrate report writing and presentation skills to an appropriately

advanced level. 8. produce students with advance knowledge and understanding to a high level in a specialised

professional/scientific area.

Learning outcomes The outcomes of the main award provide information about how the primary aims are demonstrated by students following the course. These are mapped to external reference points where appropriate6.

1 Date of original validation. 2 Date of most recent periodic review (normally academic year of validation + 5 years). 3 Month and year this version of the programme specification was approved (normally September). 4 Date programme specification will be reviewed (normally approval date + 1 year). If programme specification is applicable to

a particular cohort, please state here. 5 Date of most recent review by accrediting/ approving external body. 6 Please refer to Course Development and Review Handbook or QAA website for details.

Page 3 of 13

Knowledge and theory

On successful completion of the course the graduate should be able to: K1 demonstrate an in-depth understanding of the therapeutic process and

critically discuss its importance in Pharmacy. K2 critically discuss the aetiology and epidemiology of major diseases and

their treatment. K3 make reasoned recommendations for the drug treatment of various

pathologies in the light of published studies and procedures. K4 evaluate the influence and limitations of laboratory data on drug therapy

and patient care. K5 apply appropriate methodology for successful monitoring and evaluation of

drug usage and therapeutic outcomes. K6 interpret and evaluate prescriptions and other relevant and appropriate

orders for drugs and medicines.

K7 appraise critically a patient’s medication and formulate a pharmaceutical care plan, suggesting, where necessary, interventions that need to be made.

K8 recognise and resolve modifiable risk factors for health and appropriate means of client education and the promotion of healthy lifestyles.

K9 demonstrate an appreciation of the place of complementary and alternative therapies in modern healthcare.

K10 design and carry out an original research project, based upon novel hypotheses and analysis and utilising higher level communication skills. Gain appropriate Ethics Committee consent if required.

K11 write up original research in the style of published research or a paper.

Page 4 of 13

Skills Includes intellectual skills (i.e. generic skills relating to academic study, problem solving, evaluation, research etc.) and professional/ practical skills.

Intellectual: S1 develop critical thinking, interpretive and problem-solving capabilities. S2 develop methodologies to address hypotheses. S3 demonstrate critical appraisal skills to evaluate current research in the

discipline of pharmacy S4 use information technology effectively to gather, integrate and communicate

information relevant to pharmacy. Professional/practical: S5 apply evidence based medicine to patient care and reflect on clinical

practice. S6 elicit appropriate information from clients and the recognition of the

symptoms of common diseases with appropriate counselling and advice on the correct use of drugs and medicines, both prescribed and nonprescribed; the recognition of the need to refer major conditions.

S6 have an ability to take responsibility for, and successfully undertake, an ongoing, reflective learning programme.

S7 be competent in performing pharmaceutical calculations. S8 Critically evaluate own personal, professional and intellectual growth and

development through the process of the work-place learning. Transferable: S9 demonstrate use of appropriate communication to gain the co-operation of

relevant stakeholders (including patients, senior and peer colleagues, and other professionals where possible).*

S10 demonstrate ability to use skills to make decisions in complex situations where there are several factors that require analysis, interpretation and comparison.*

S11 demonstrate ability to work as a member of a team.* S12 take action based on own interpretation of broad professional

policies/procedures where necessary.* *These skills have been mapped to the RPS Advanced Pharmacy Framework

2013.

QAA subject benchmark statement (where applicable)7

Master’s Degree Characteristics (QAA, September 2015) https://www.qaa.ac.uk/docs/qaa/quality-code/master%27s-degreecharacteristics-statement.pdf?sfvrsn=6ca2f981_10 Qualifications Framework https://www.qaa.ac.uk/docs/qaa/quality-code/qualifications-frameworks.pdf The revised UK Quality Code for Higher Education (March 2018) https://www.qaa.ac.uk/docs/qaa/quality-code/revised-uk-quality-code-for-highereducation.pdf?sfvrsn=4c19f781_8 A subject benchmark for Pharmacy PG courses does not exist, however a benchmark for Pharmacy (MPharm) does which comprises one year of level 7 (see http://www.qaa.ac.uk/en/Publications/Documents/Subject-benchmarkstatement---Pharmacy.pdf)

7 Please refer to the QAA website for details.

Page 5 of 13

PROFESSIONAL, STATUTORY AND REGULATORY BODIES (where applicable) Where a course is accredited by a PSRB, full details of how the course meets external requirements, and what students are required to undertake, are included.

N/A This course does not provide a route for international pharmacists to become eligible for GPhC registration.

LEARNING AND TEACHING Learning and teaching methods This section sets out the primary learning and teaching methods, including total learning hours and any specific requirements in terms of practical/ clinical-based learning. The indicative list of learning and teaching methods includes information on the proportion of the course delivered by each method and details where a particular method relates to a particular element of the course. The course aims to provide a wide range of learning experiences so that students with different learning styles may benefit, and extension of these to other styles will be encouraged. A learning styles questionnaire will be completed by the students during the first workshop of PYM56. The course will be delivered via a mixture of:

• Lectures and seminars • Tutorials • Practical sessions • Reflective portfolio work • Workshops • Guided and free student centred study • Directed web-based study • Project work • Clinical placement • Peer support • Spending time with experts in the field of practice

For details of the learning experience for applicants wishing to take the Extended Masters route see https://www.brighton.ac.uk/international/study-with-us/courses-and-qualifications/brighton-languageinstitute/courses/extended-masters-route/index.aspx)

ASSESSMENT

Assessment methods This section sets out the summative assessment methods on the course and includes details on where to find further information on the criteria used in assessing coursework. It also provides an assessment matrix which reflects the variety of modes of assessment, and the volume of assessment in the course.

All modules are assessed using the assessment criteria detailed on the individual modules descriptions, which are linked to the learning outcomes for that module as stated in the module descriptor. All students will encounter the following general types of assessment: • case-study and problem-based assignments • reflective portfolios - these will be used both summatively and formatively • project poster presentation and viva voce • written examinations • oral presentations – used both summatively and formatively • web lecture tests - used formatively only • mini-projects • research proposal • research project dissertation

The matrix below maps assessments to learning outcomes.

Page 6 of 13

Learning Outcome Assessment method Module Number

of credits 1. Demonstrate an in-depth understanding

of the therapeutic process and critically discuss its importance in Pharmacy.

Exam Coursework (final report)

PYM38 PYM22

20 60

2. Critically discuss the aetiology and epidemiology of major diseases and their treatment.

Exam and coursework (care plan, critical appraisal) Coursework (final report) and practical (viva voce/poster presentation)

PYM38 PYM22

20 60

3. Make reasoned recommendations for the drug treatment of various pathologies in the light of published studies and procedures.

Exam and coursework (care plan) Coursework (final report) and practical (viva voce/poster presentation)

PYM38 PYM22

20 60

4. Evaluate the influence and limitations of laboratory data on drug therapy and patient care.

Exam and coursework (care plan) Coursework (final report) and practical (viva voce/poster presentation)

PYM38 PYM22

20 60

5. Apply appropriate methodology for successful monitoring and evaluation of drug usage and therapeutic outcomes.

Exam and coursework (care plan) Coursework (final report)

PYM38 PYM22

20 60

6. Interpret and evaluate prescriptions and other relevant and appropriate orders for drugs and medicines.

Coursework (care plan) and exam Practical (OSCE)

PYM38 PYM59

20 40

7. Appraise critically a patient’s medication and formulate a pharmaceutical care plan, suggesting, where necessary, interventions that need to be made.

Coursework (care plan) PYM38 20

8. Recognise and resolve modifiable risk factors for health and appropriate means of client education and the promotion of healthy lifestyles.

Coursework (written critique) Practical (OSCE)

PYM43 PYM59

10 40

9. Demonstrate an appreciation of the place of complementary and alternative therapies in modern healthcare.

Exam Coursework (portfolio) and practical (OSCE)

PYM38 PYM59

20 40

10. Design and carry out an original research project, based upon novel hypotheses and analysis and utilising higher level communication skills. Gain appropriate Ethics Committee consent if required.

Coursework (final report) and practical (viva voce/poster presentation)

PYM22 60

11. Write up original research in the style of published research or a paper.

Coursework (final report) PYM22 60

12. Critically evaluate the evidence base for

practice and use the product of this analysis to plan innovative ways of working in practice

Coursework (portfolio)

PYM59 40

13. Critically appraise how best practice can be implemented.

Coursework (portfolio)

PYM59 40

14. Synthesise knowledge and experience from research and theoretical literature, and practice, in devising strategies for managing and evaluating change in practice,

Coursework (portfolio) Coursework (critique)

PYM59

PYM43 40

10

15. Develop critical thinking, interpretive and problem-solving capabilities.

Coursework (critical appraisal, care plan) and exam Coursework (portfolio) and practical (OSCE) Coursework (lit. review) Coursework (written critique, essay) Coursework (project proposal) Coursework (final report)

PYM38 PYM59 PYM21 PYM43 PYM56 PYM22

20 40 20 10 20 60

Page 7 of 13

16. Develop methodologies to address hypotheses.

Coursework (project proposal) Coursework (final report)

PYM56 PYM22

20 60

17. Demonstrate critical appraisal skills to evaluate current research in the discipline of pharmacy.

Coursework (final report) Coursework (critical appraisal) Coursework (written critique) Coursework (project proposal) Coursework (lit. review)

PYM22 PYM38 PYM43 PYM56 PYM21

60 20 10 20 20

18. Use information technology effectively to gather, integrate and communicate information relevant to pharmacy.

Coursework (final report and practical (viva voce/poster presentation) Coursework (written critique) and practical (presentation) Coursework (portfolio) and practical (OSCE) Coursework (project proposal)

PYM22 PYM43 PYM59 PYM56

60 10 40 20

19. Apply evidence based medicine to patient care and reflect on clinical practice

Coursework (critical appraisal, care plan) and exam Coursework (written critique) and practical (presentation) Coursework (portfolio) and practical (OSCE)

PYM38 PYM43 PYM59

20. Elicit appropriate information from clients and the recognition of the symptoms of common diseases with appropriate counselling and advice on the correct use of drugs and medicines, both prescribed and non-prescribed; the recognition of the need to refer major conditions.

Practical (OSCE) PYM59 40

21. Have an ability to take responsibility for, and successfully undertake, an ongoing, reflective learning programme.

Coursework (self-evaluation) Coursework (portfolio) Coursework (final report)

PYM56 PYM59 PYM22

20 40 60

22. Be competent in performing pharmaceutical calculations.

Coursework (portfolio) and practical (OSCE)

PYM59 40

23. Demonstrate use of appropriate communication to gain the co-operation of relevant stakeholders (including patients, senior and peer colleagues, and other professionals where possible).*

Coursework (lit. review) and practical (portfolio, seminars) Coursework (written critique, essay) and practical (presentation) Practical (viva voce/poster presentation)

PYM21 PYM43 PYM22

20 10 60

24. Demonstrate ability to use skills to make decisions in complex situations where there are several factors that require analysis, interpretation and comparison.*

Coursework (critical appraisal, care plan) and exam Coursework (portfolio) and practical (OSCE) Coursework (written critique, essay) and practical (presentation)

PYM38 PY59 PYM43 PYM21

20 40 10 20

Coursework (lit. review) and practical (portfolio, seminars) Coursework (final report) and practical (viva voce/poster presentation) Coursework (project proposal, self evaluation)

PYM22 PYM56

60 20

25. Demonstrate ability to work as a member of a team.*

Coursework (portfolio) Coursework (written critique) and practical (presentation)

PYM59 PYM43

40 10

26. Is able to take action based on own interpretation of broad professional policies/procedures where necessary.*

Coursework (self-evaluation) PYM56 20

27. Appreciate the rationale underlying UK clinical pharmacy practice and apply it to their own national working environment to identify good practice.

Coursework (portfolio)

PYM59

40

28. Appreciate the unique role of the pharmacist within a multi-profession healthcare team

Coursework (portfolio) Coursework (written critique)

PYM59 PYM43

40 10

Page 8 of 13

* These skills have been mapped to the RPS Advanced Pharmacy Framework 2013.

SUPPORT AND INFORMATION Institutional/ University All students benefit from:

• University induction week programme • University student contract

https://www.brighton.ac.uk/currentstudents/my-studies/student-policies-

and-regulations/index.aspx • Course Handbook • Extensive library facilities centred in main Aldrich library • Computer pool rooms: Six open access computer pool rooms on the

Moulsecoomb site with over 200 workstations (and a further 450 network points for personal PCs in the library). All are linked to the University network services and have daily user support help desk))

• External and internal E-mail and internet access, and may set up personal websites

• Student services, including Welfare, Careers, Counselling, Legal, Financial, Accommodation, Childcare, Medical, Sexual Health and Chaplaincy support

• Studentcentral • iASK Study Skills Toolkit • Student support and guidance tutor • Careers Planning Agreement • Personal academic tutor

Course-specific Additional support, specifically where courses have non- traditional patterns of delivery (e.g. distance learning and work-based learning) include:

In addition, students on this course benefit from: • School Safety Policy • Studentcentral course specific areas Small group tutorials • Specialist facilities (inc. SimMan and clinical skills lab) Students undertaking the clinical experience route will also benefit from: • Spending time with experts in the field of practice • Partner hospital facilities Specialist facilities including the following: High field NMR; Time-of-flight high resolution and ion-trap ESI- mass spectrometry; UV/Vis, near infra-red, mid infra-red, Raman spectrophotometry; Fluorimetry; HPLC; GLC; Particle size and zeta potential; Rheometry; Differential scanning calorimetry; UV/Vis plate readers; MS

Page 9 of 13

Tablet press; Dosage form evaluation equipment including dissolution, disintegration apparatus; Twin stage and multistage liquid impingers; Texture analysis. Specialist pharmacology equipment; Ultracentrifuge; Autoclaves; Electrophysiology equipment. Microscopy suite including electron, confocal and atomic force microscopy Tissue culture suite Histology facilities Clinical Skills Laboratory with simulated patient mannequins (SimMan) and clinical dummies (Resusci Anne) Research Informed teaching The course is delivered within a highly research active environment. Outcomes recently announced confirmed that in this unit of assessment 82% of our healthcare research was classified as world leading or internationally excellent, with 87.5% of our research environment and 80% of our research impact being world leading. In the Research Excellence Framework (REF) 2014, the school submitted into the A3 unit of assessment with colleagues from Nursing and Allied Health Professionals and the Medical School (now School of Health Sciences) (see http://www.brighton.ac.uk/lhp-research-groups/pharmacy-health-andbiomolecular-sciences/index.aspx for details). The course team is able to use and contextualise the strong research base, so that the research becomes applied in the module in which it is taught. For example in PYM38 (Applied Therapeutics) students are required to critically appraise a drug trial. Part of this task is to evaluate the drugs current place in clinical practice. Thus the student must be aware of the current evidence and research supporting that drug and the condition for which it is being used Alongside this, the representation of current practitioners means that there is a strong emphasis on the use of current medical and pharmaceutical guidelines and good practice and on understanding the research that underpins these. The Lecturers and teacher practitioners involved in the teaching, assessment and development of the course include those from primary (both community pharmacy and clinical commissioning groups) and secondary care. The majority of the senior lecturers who teach on the course have an extensive clinical pharmacy background, which includes specialists in mental health, paediatrics and cardiology. Having current, specialist practitioners involved with the course ensure that the knowledge and skills that are taught and assessed are current and research based. Education for Sustainable Development Sustainable Development - Technological developments arise out of science, and problems generated by development are solved by knowledge gained from further science. Therefore the course educates students for sustainable development by studying science and developing scientific skills, research skills and critical thinking.

Page 10 of 13

PART 3: COURSE SPECIFIC REGULATIONS COURSE STRUCTURE This section includes an outline of the structure of the programme, including stages of study and progression points. Course Leaders may choose to include a structure diagram here.

The full time MSc structure will be as follows:

Clinical

Research methods (PYM56,

20 credits)

Pharmaceutical Skills for Clinical

Pharmacy (PYM59,

40 credits)

Applied Therapeutics

(PYM38, 20 credits)

Current Research in Pharmacy (PYM21,

20 credits)

Clinical Pharmacy

Project (PYM22,

60 credits)

Special Topic

(10 credits)

Health Promotion for Pharmacists

(PYM43, 10 credits)

Part time students may take modules PYM38, PYM39, PYM43, PYM21 and the Special Topic in any order over 1 or 2 years. It is expected that PYM56 and the project will be studied together either in the second year with other taught modules or in the third year. Normally this would mean that PYM21 and PYM59 would be studied in one year and the remaining taught modules studied in the other year thereby allowing an even distribution of credit throughout the study period. These alternatives are illustrated in the structures below:

Part time MSc over 2 years Part time MSc over 3 years

Academic year Modules Year 1 PYM21 (20 credits)

PYM38 (20 credits) PYM59 (40 credits) PYM43 (10 credits)

Special topic (10 credits)

PYM21 (20 credits) PYM59 (40 credits)

Year 2 PYM56 (20 credits) PYM22 (60 credits)

PYM38 (20 credits) PYM43 (10 credits)

Special topic (10 credits) Year 3 PYM22 (60 credits)

PYM56 (20 credits) These part time routes are only available to Home/EU students. Students may be allowed to take a Special Topic in Semester 1 based on interest subject to timetabling constraints and course leader agreement.

11 of 13

Modules Level8

Module code

Status Module title Credit

7 PYM04 O Specialised Clinical Practice 10 7 PYM05 O Advanced Diabetes Therapies 10 7 PYM09 O Pharmaceutical Care of Surgical Patients 10 7 PYM10 O Global Perspectives on Health and Medicines 10

7 PYM13 O Ageing: pathology and prevention 10

7 PYM14 O Cancer: bench to bedside 10

7 PYM15 O Understanding Age-Related CNS Disorders 10

7 PYM21 C Current research in pharmacy 20 7 PYM22 M MSc Clinical Pharmacy project 60 7 PYM38 M Applied therapeutics 20 7 PYM59 C Pharmaceutical skills for Clinical Pharmacy 40 7 PYM43 C Health promotion for pharmacists 10 7 PYM56 C Clinical Research methods 20 7 BYM32 O Regenerative Medicine and Medical Devices 10

7 PBM20 O Controversies in Science 10

Status: M = Mandatory (modules which must be taken and passed to be eligible for the award) C = Compulsory (modules which must be taken to be eligible for the award) O = Optional (optional modules)* * Optional modules listed are indicative only and may be subject to change, depending on timetabling and staff availability

8 All modules have learning outcomes commensurate with the FHEQ levels 0, 4, 5, 6, 7 and 8. List the level which corresponds

with the learning outcomes of each module.

Page

AWARD AND CLASSIFICATION Award type Award* Title Level Eligibility for award Classification of award

Total credits9 Minimum credits10 Ratio of marks11: Class of award

Final MSc Clinical Pharmacy 7 Total credit 180 Minimum credit at level of award 150

Level 7 marks Postgraduate degree

Intermediate PGDip Clinical Pharmacy 7 Total credit 120 Minimum credit at level of award 90

Level 7 marks Postgraduate (taught) degree

Intermediate PGCert Clinical Pharmacy 7 Total credit 60 Minimum credit at level of award 40

Level 7 marks Postgraduate (taught) degree

Select Select Total credit Select Minimum credit at level of award Select

Select Select

Select Select Total credit Select Minimum credit at level of award Select

Select Select

*Foundation degrees only Progression routes from award:

Award classifications

Mark/ band % Foundation degree Honours degree Postgraduate12 degree (excludes PGCE and BM BS)

70% - 100% Distinction First (1) Distinction 60% - 69.99% Merit Upper second (2:1) Merit 50% - 59.99%

Pass Lower second (2:2) Pass

40% - 49.99% Third (3)

9 Total number of credits required to be eligible for the award. 10 Minimum number of credits required, at level of award, to be eligible for the award. 11 Algorithm used to determine the classification of the final award (all marks are credit-weighted). For a Masters degree, the mark for the final element (e.g, dissertation) must be in the corresponding

class of award. 12 Refers to taught provision: PG Cert, PG Dip, Masters.

Page 12 of 13

EXAMINATION AND ASSESSMENT REGULATIONS Please refer to the Course Approval and Review Handbook when completing this section. The examination and assessment regulations for the course should be in accordance with the University’s General Examination and Assessment Regulations for Taught Courses (available from staffcentral or studentcentral). Specific regulations which materially affect assessment, progression and award on the course e.g. Where referrals or

repeat of modules are

not permitted in line with

the University’s General Examination and Assessment Regulations for Taught Courses.

Exception to GEAR has been granted to permit RPL of 120 level 7 credits for direct entrants (to either MSc route) who have previously completed an equivalent PGDiploma.

Exceptions required by PSRB These require the approval of the Chair of the Academic Board

Page 13 of 13